Amit Bhalla Navidea Biopharmaceuticals, Inc. (NAVB) insider trading activity

Amit Bhalla is Director of NAVIDEA BIOPHARMACEUTICALS, INC.. Currently has a direct ownership of 71,818 shares of NAVB, which is worth approximately $0. The most recent transaction as insider was on Nov 30, 2022, when has been sold 1,250 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 71.8K

0% 3M change

0% 12M change

Total Value Held $0

Amit Bhalla Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Nov 30 2022	BUY Grant, award, or other acquisition	-	1,250 Added 1.71%	71,818 Common Stock
Oct 31 2022	BUY Grant, award, or other acquisition	-	2,500 Added 3.42%	70,568 Common Stock
Sep 30 2022	BUY Grant, award, or other acquisition	-	2,500 Added 3.54%	68,068 Common Stock
Aug 31 2022	BUY Grant, award, or other acquisition	-	2,500 Added 3.67%	65,568 Common Stock
Jul 31 2022	BUY Grant, award, or other acquisition	-	2,500 Added 3.81%	63,068 Common Stock
Jun 30 2022	BUY Grant, award, or other acquisition	-	2,500 Added 3.96%	60,568 Common Stock
May 31 2022	BUY Grant, award, or other acquisition	-	2,500 Added 4.13%	58,068 Common Stock
Apr 30 2022	BUY Grant, award, or other acquisition	-	2,500 Added 4.31%	55,568 Common Stock
Mar 31 2022	BUY Grant, award, or other acquisition	-	2,500 Added 4.5%	53,068 Common Stock
Feb 28 2022	BUY Grant, award, or other acquisition	-	2,500 Added 4.71%	50,568 Common Stock
Jan 31 2022	BUY Grant, award, or other acquisition	-	2,500 Added 4.94%	48,068 Common Stock
Dec 31 2021	BUY Grant, award, or other acquisition	-	2,500 Added 5.2%	45,568 Common Stock
Nov 30 2021	BUY Grant, award, or other acquisition	-	1,250 Added 2.82%	43,068 Common Stock
Nov 15 2021	BUY Grant, award, or other acquisition	-	32,623 Added 43.82%	41,818 Common Stock
Sep 30 2021	BUY Grant, award, or other acquisition	-	4,286 Added 31.79%	9,195 Common Stock
Jun 30 2021	BUY Grant, award, or other acquisition	-	2,409 Added 32.92%	4,909 Common Stock
May 04 2021	BUY Grant, award, or other acquisition	-	2,500 Added 50.0%	2,500 Common Stock

Amit Bhalla

Director

Dublin, OH

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NAVB shares.

Notify only if

Value

Insider Trading

Get notified when an Navidea Biopharmaceuticals, Inc. insider buys or sells NAVB shares.

Notify only if

Operation

Value

Type

News

Receive news related to NAVIDEA BIOPHARMACEUTICALS, INC.

Track Activities on NAVB

Account